The Effects of Resveratrol Supplementation on Inflammation and Cognitive Performance in Healthy Adults
Launched by NORTHUMBRIA UNIVERSITY · Mar 17, 2020
Trial Information
Current as of April 29, 2025
Completed
Keywords
ClinConnect Summary
Each participant will be required to attend the laboratory on three occasions. The first of these will be an initial screening/training visit, this will take place in the afternoon and last 2 1/2 hours in total. During the initial visit participants will be asked to provide written informed consent. They will provide lifestyle and demographic data and screened regards to physical health (height, weight, blood pressure, waist to hip ratio). They will then complete a food frequency questionnaire and be trained on the computerised cognitive and mood tasks. Participants will also be trained on ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants must self-assess themselves as being in good health.
- • Aged 18 to 55 at the time of giving consent
- Exclusion Criteria:
- • Have a Body Mass Index (BMI) outside the range of 18.5-42kg/m2
About Northumbria University
Northumbria University is a leading research-intensive institution based in the UK, dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, the university leverages its academic expertise and state-of-the-art facilities to conduct high-quality research aimed at improving patient outcomes and informing clinical practices. With a commitment to ethical standards and regulatory compliance, Northumbria University collaborates with healthcare professionals and industry partners to explore novel therapeutic interventions and contribute to the body of evidence that shapes modern medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Newcastle Upon Tyne, Tyne And Wear, United Kingdom
Patients applied
Trial Officials
Emma L Wightman, Dr
Principal Investigator
Northumbria University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials